Cargando…
Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
Inflammatory bowel diseases (IBD) is featured by gastrointestinal inflammation and a disease course with alternating recurrence and remission. The global burden caused by IBD has significantly boosted in recent years, necessitating treatment optimization. Serum amyloid A (SAA) is a class of 104 amin...
Autores principales: | Chen, Rirong, Chen, Qia, Zheng, Jieqi, Zeng, Zhirong, Chen, Minhu, Li, Li, Zhang, Shenghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172326/ https://www.ncbi.nlm.nih.gov/pubmed/37164984 http://dx.doi.org/10.1038/s41420-023-01455-5 |
Ejemplares similares
-
Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021) -
Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023) -
Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022) -
Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022) -
Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)